Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Ineffable Intelligence, a British AI lab founded a mere few months ago by former DeepMind researcher David Silver, has raised $1.1 billion in funding at a valuation of $5.1 billion.
The legendary Google executive is joined by other outgoing Google execs in a joint mission to use AI to push forward the process of scientific discovery.
Jumper isn’t the only big name leaving Google DeepMind.
Google DeepMind and A24 are teaming up to build AI filmmaking tools.
DeepMind CEO Demis Hassabis is proposing an AI “standards body” modeled after FINRA, to test frontier models and develop best practices for their release.